A Physiologically Based Pharmacokinetic Drug–Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows
Crossref DOI link: https://doi.org/10.1007/s40262-015-0253-7
Published Online: 2015-03-14
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rasool, Muhammad Fawad
Khalil, Feras
Läer, Stephanie
License valid from 2015-03-14